Efficacy and safety of eltrombopag in the treatment of Chinese children with chronic immune thrombocytopenia.
Sign Up to like & getrecommendations! Published in 2021 at "Hematology"
DOI: 10.1080/16078454.2020.1856511
Abstract: OBJECTIVES Our aim is to evaluate initial efficacy, safety, and durable response of eltrombopag in the treatment of Chinese children with chronic immune thrombocytopenia (cITP). METHODS This was a retrospective, single-center cohort study including 30… read more here.
Keywords: response; efficacy safety; eltrombopag treatment; durable response ... See more keywords